Glenmark Pharmaceuticals has announced that it has received ANDA approval for Clotrimazole and Betamethasone Dipropionate Cream USP, 1% | 0.05%
Glenmark Pharmaceuticals Ltd is currently trading at Rs. 945.35, down by Rs. 15.6 or 1.62% from its previous closing of Rs. 960.95 on the BSE.
The scrip opened at Rs. 947 and has touched a high and low of Rs. 951 and Rs. 934.55 respectively. So far 48719(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 27113.8 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1261.95 on 21-Aug-2015 and a 52 week low of Rs. 703.5 on 07-Jan-2015. Last one week high and low of the scrip stood at Rs. 998.9 and Rs. 950.5 respectively.
The promoters holding in the company stood at 46.45 % while Institutions and Non-Institutions held 42.81 % and 10.75 % respectively.
The stock is currently trading above its 100 DMA.
No comments:
Post a Comment